Alexandre de Germay - 27 Feb 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
Susan E. Grant, by power of atty., for Alexandre de Germay
Issuer symbol
PFE
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
4
Filing time
28 Feb 2024, 16:58:40 UTC
Previous filing
21 Dec 2023
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Award $0 +74,377 $0.000000 74,377 27 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +89,533 $0.000000 89,533 27 Feb 2024 Common Stock 89,533 $26.89 Direct F2
transaction PFE Stock Appreciation Rights Award $0 +79,111 $0.000000 79,111 27 Feb 2024 Common Stock 79,111 $26.89 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.